Detalhe da pesquisa
1.
Long-Term Compassionate Use of Cefiderocol To Treat Chronic Osteomyelitis Caused by Extensively Drug-Resistant Pseudomonas aeruginosa and Extended-Spectrum-ß-Lactamase-Producing Klebsiella pneumoniae in a Pediatric Patient.
Antimicrob Agents Chemother
; 64(4)2020 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31871075
2.
Role of Renal Drug Exposure in Polymyxin B-Induced Nephrotoxicity.
Antimicrob Agents Chemother
; 61(4)2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28096166
3.
Dosing and Pharmacokinetics of Polymyxin B in Patients with Renal Insufficiency.
Antimicrob Agents Chemother
; 61(1)2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27799209
4.
Evaluation of Urinary KIM-1 for Prediction of Polymyxin B-Induced Nephrotoxicity.
Antimicrob Agents Chemother
; 61(11)2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28848003
5.
Significant Publications on Infectious Diseases Pharmacotherapy in 2019.
J Pharm Pract
; 34(5): 800-813, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32935641
6.
Outcomes of empiric aminoglycoside monotherapy for Pseudomonas aeruginosa bacteremia.
Diagn Microbiol Infect Dis
; 93(4): 346-348, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30522794
7.
Population Pharmacokinetics of Polymyxin B.
Clin Pharmacol Ther
; 104(3): 534-538, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29238962
8.
Significant publications on infectious diseases pharmacotherapy in 2015.
Am J Health Syst Pharm
; 74(4): 238-252, 2017 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28082303